Related Experiment Video

Updated: May 4, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

16.2K

Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation

Boris G Wilson1, Katherine C Helming, Xiaofeng Wang

  • 1Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Molecular and Cellular Biology
|January 15, 2014
PubMed

Insights

Mutations in SWI/SNF chromatin remodeling genes, especially SMARCA4, drive cancer. A SMARCA2-containing complex becomes essential in SMARCA4-mutant cancers, revealing SMARCA2 as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • SWI/SNF (BAF) chromatin remodeling complex genes are frequently mutated in human cancers, with SMARCA4 (BRG1) being a common target.
  • The SWI/SNF complex utilizes two catalytic subunits, SMARCA4 and SMARCA2 (BRM), which modulate chromatin remodeling.
  • SMARCA4 mutations are prevalent in various cancers, impacting cellular processes.

Purpose of the Study:

  • To investigate the role of a residual SWI/SNF complex in SMARCA4-mutant cancers.
  • To identify potential therapeutic targets in cancers with SMARCA4 loss.
  • To elucidate the mechanism by which SMARCA4 inactivation affects SWI/SNF complex composition.

Main Methods:

  • Analysis of SMARCA4-mutant cancer cell lines to detect residual SWI/SNF complexes.
  • Loss-of-function genetic screening across 165 cancer cell lines.
  • Mechanistic studies to understand subunit incorporation into the SWI/SNF complex upon SMARCA4 inactivation.

Main Results:

  • A SMARCA2-containing residual SWI/SNF complex was identified in SMARCA4-mutant cell lines, essential for proliferation.
  • SMARCA2 was confirmed as an essential gene in SMARCA4-mutant cancer cell lines through loss-of-function screening.
  • SMARCA4 inactivation promotes the incorporation of the SMARCA2 subunit into the SWI/SNF complex.

Conclusions:

  • The SMARCA2-containing SWI/SNF complex plays a critical role in the oncogenesis of SMARCA4-mutant cancers.
  • SMARCA2 is identified as a potential therapeutic target for cancers with SMARCA4 loss.
  • Understanding SWI/SNF complex dynamics offers insights into cancer development and treatment strategies.

More Related Videos

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer06:01

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

Published on: July 6, 2017

9.1K
gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

11.6K

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

2.1K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.0K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
5.7K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.6K